Resolution number 695, 13 May 2022; (9 page(s), in Portuguese)

Draft amendments to the Rules for marketing authorization and assessment of medicinal products for human use; (24 page(s), in Russian)

Nonprescription Drug Product With an Additional Condition for Nonprescription Use; (19 page(s), in English)